Therefore, the upregulation of GSTZ1 in PRAD reflects an adaptive response to the tissue-specific microenvironment, balancing mitochondrial metabolism and immunological crosstalk to promote PRAD progression. The gene discussed is GSTZ1; the disease is prostate adenocarcinoma.